CLEW, an Israeli medtech firm specializing in real-time AI analytics platforms, received approval from the United States Food and Drug Administration (FDA) for its “Predictive Analytics Platform in Support of COVID-19 Patients,” the company announced Tuesday.
The Intensive Care Unit (ICU) solution was given Emergency Use Authorization (EUA) by the FDA so that it may be implemented within the United States’ health system as soon as possible.
Comments are closed.